With a fresh leadership team…
With a fresh leadership team settling in, CNS Pharmaceuticals is [...]
Salspera has set out plans for a…
Salspera has set out plans for a $91 million IPO [...]
Sandoz is committing even further…
Sandoz is committing even further to its biosimilar business with [...]
In his second year as CEO,…
In his second year as CEO, AbbVie’s Robert Michael received [...]
Less than a week after Roche…
Less than a week after Roche pledged a hefty investment [...]
Molecular glue-focused biotech f5…
Molecular glue-focused biotech f5 Therapeutics has failed to stick around [...]
Pharmas’ direct drug sale…
Pharmas’ direct drug sale platforms could be the key to [...]
The FDA has resumed review of…
The FDA has resumed review of Capricor Therapeutics’ previously rejected [...]
The FDA’s newest draft guidance…
The FDA’s newest draft guidance reinforces its previous commitment to [...]
With sales booming at Eli Lilly,…
With sales booming at Eli Lilly, the Indianapolis company has [...]